» Articles » PMID: 36031301

Breathing Disturbances in Rett Syndrome

Overview
Publisher Elsevier
Specialty Neurology
Date 2022 Aug 28
PMID 36031301
Authors
Affiliations
Soon will be listed here.
Abstract

Rett Syndrome is an X-linked neurological disorder characterized by behavioral and neurological regression, seizures, motor deficits, and dysautonomia. A particularly prominent presentation includes breathing abnormalities characterized by breathing irregularities, hyperventilation, repetitive breathholding during wakefulness, obstructive and central apneas during sleep, and abnormal responses to hypoxia and hypercapnia. The condition and pathology of the respiratory system is further complicated by dysfunctions of breathing-motor coordination, which is reflected in dysphagia. The discovery of the X-linked mutations in the MECP2 gene has transformed our understanding of the cellular and molecular mechanisms that are at the root of various clinical phenotypes. However, the genotype-phenotype relationship is complicated by various factors which include not only X-inactivation but also consequences of the intermittent hypoxia and oxidative stress associated with the breathing abnormalities.

Citing Articles

A brainstem map of orofacial rhythms.

Kaku H, Liu L, Gao R, West S, Liao S, Finkelstein A bioRxiv. 2025; .

PMID: 39975015 PMC: 11838403. DOI: 10.1101/2025.01.27.635041.


24-h continuous non-invasive multiparameter home monitoring of vitals in patients with Rett syndrome by an innovative wearable technology: evidence of an overlooked chronic fatigue status.

Leoncini S, Boasiako L, Di Lucia S, Beker A, Scandurra V, Vignoli A Front Neurol. 2024; 15:1388506.

PMID: 38952469 PMC: 11215834. DOI: 10.3389/fneur.2024.1388506.


Chronic intermittent hypoxia elicits distinct transcriptomic responses among neurons and oligodendrocytes within the brainstem of mice.

Bhagavan H, Wei A, Oliveira L, Aldinger K, Ramirez J Am J Physiol Lung Cell Mol Physiol. 2024; 326(6):L698-L712.

PMID: 38591125 PMC: 11380971. DOI: 10.1152/ajplung.00320.2023.


The Efficacy of a Human-Ready mini Gene Therapy in a Pre-Clinical Model of Rett Syndrome.

Sadhu C, Lyons C, Oh J, Jagadeeswaran I, Gray S, Sinnett S Genes (Basel). 2024; 15(1).

PMID: 38254921 PMC: 10815157. DOI: 10.3390/genes15010031.


Inhibitory synaptic transmission is impaired in the Kölliker-Fuse of male, but not female, Rett syndrome mice.

Whitaker-Fornek J, Jenkins P, Levitt E J Neurophysiol. 2023; 130(6):1578-1587.

PMID: 37965930 PMC: 11068392. DOI: 10.1152/jn.00327.2023.


References
1.
Samaco R, Mandel-Brehm C, Chao H, Ward C, Fyffe-Maricich S, Ren J . Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities. Proc Natl Acad Sci U S A. 2009; 106(51):21966-71. PMC: 2799790. DOI: 10.1073/pnas.0912257106. View

2.
Kubin L, Alheid G, Zuperku E, McCrimmon D . Central pathways of pulmonary and lower airway vagal afferents. J Appl Physiol (1985). 2006; 101(2):618-27. PMC: 4503231. DOI: 10.1152/japplphysiol.00252.2006. View

3.
Forbes-Lorman R, Kurian J, Auger A . MeCP2 regulates GFAP expression within the developing brain. Brain Res. 2013; 1543:151-8. DOI: 10.1016/j.brainres.2013.11.011. View

4.
Pozzo-Miller L, Pati S, Percy A . Rett Syndrome: Reaching for Clinical Trials. Neurotherapeutics. 2015; 12(3):631-40. PMC: 4489949. DOI: 10.1007/s13311-015-0353-y. View

5.
Moreira T, Takakura A, Colombari E, Guyenet P . Activation of 5-hydroxytryptamine type 3 receptor-expressing C-fiber vagal afferents inhibits retrotrapezoid nucleus chemoreceptors in rats. J Neurophysiol. 2007; 98(6):3627-37. DOI: 10.1152/jn.00675.2007. View